(Q24816597)

2

0 references

Lehana Thabane

6

0 references

Amiram Gafni

4

object named as

Amiram Gafni

0 references

Jonathan D Adachi

3

object named as

Jonathan D Adachi

0 references

David A Hanley

5

object named as

David A Hanley

0 references

author name string

Anna M Sawka

BMC Musculoskeletal Disorders

1

0 references

language of work or name

English

0 references

publication date

11 July 2005

5 references

18 June 2019

12 November 2019

6 January 2020

29 October 2020

16 July 2021

5 references

18 June 2019

12 November 2019

6 January 2020

29 October 2020

16 July 2021

6

0 references

issue

1

0 references

page(s)

39

0 references

copyright license

Creative Commons Attribution 2.0 Generic

5 references

18 June 2019

12 November 2019

6 January 2020

29 October 2020

Alendronate Treatment in Men With Primary Osteoporosis: A Three-Year Longitudinal Study

16 July 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Treatment of male osteoporosis: recent advances with alendronate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Bayesian methods in health technology assessment: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Methods in health service research. An introduction to bayesian methods in health technology assessment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

The worldwide problem of osteoporosis: insights afforded by epidemiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Effects of alendronate on bone density in men with primary and secondary osteoporosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Assessment of vertebral fractures in osteoporosis research.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

Alendronate in the prevention of bone loss after a fracture of the lower leg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

Assessing the Quality of Randomised Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-6-39

Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182376

Bisphosphonates in the treatment of osteoporosis

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16008835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2474-6-39

1 reference

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2474-6-39

1 reference

1 reference

PubMed publication ID

16008835

1 reference